Compounds > 4-(2-aminoethyl)benzenesulfonamide
Page last updated: 2024-09-05

4-(2-aminoethyl)benzenesulfonamide and Benign Neoplasms

4-(2-aminoethyl)benzenesulfonamide has been researched along with Benign Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Franchi, M; Gallori, E; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D1
Casini, A; Lehtonen, JM; Parkkila, S; Scozzafava, A; Supuran, CT; Vullo, D1
Cecchi, A; Fasolis, G; Gamberi, A; Montero, JL; Puccetti, L; Scozzafava, A; Supuran, CT; Winum, JY1
Bornaghi, LF; Charman, SA; Innocenti, A; Lopez, M; Poulsen, SA; Supuran, CT; Vullo, D1
Chen, L; Chen, W; Huang, S; Jin, Q; Li, Y; Liu, J; Liu, N; Liu, Q; Wang, P; Zhu, X; Zuo, W1

Other Studies

5 other study(ies) available for 4-(2-aminoethyl)benzenesulfonamide and Benign Neoplasms

ArticleYear
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
    Bioorganic & medicinal chemistry letters, 2003, Mar-24, Volume: 13, Issue:6

    Topics: Animals; Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cattle; Heterocyclic Compounds; Humans; Hydrocarbons, Aromatic; Isoenzymes; Kinetics; Neoplasm Proteins; Neoplasms; Structure-Activity Relationship; Sulfonamides

2003
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
    Bioorganic & medicinal chemistry letters, 2004, Jul-16, Volume: 14, Issue:14

    Topics: Amino Acid Sequence; Animals; Carbonic Anhydrase Inhibitors; Cytosol; Drug Design; Humans; Hydrogen-Ion Concentration; Isoenzymes; Kinetics; Molecular Sequence Data; Neoplasms; Rats; Structure-Activity Relationship; Sulfonamides

2004
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Bioorganic & medicinal chemistry letters, 2005, May-02, Volume: 15, Issue:9

    Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Catalytic Domain; Cytosol; Humans; Kinetics; Neoplasms; Structure-Activity Relationship; Sulfonamides; Urea

2005
Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases.
    Journal of medicinal chemistry, 2010, Apr-08, Volume: 53, Issue:7

    Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Membrane Permeability; Glycoconjugates; Humans; Isoenzymes; Neoplasms; Structure-Activity Relationship; Sulfonamides

2010
Macrophage-Mimic Hollow Mesoporous Fe-Based Nanocatalysts for Self-Amplified Chemodynamic Therapy and Metastasis Inhibition
    ACS applied materials & interfaces, 2022, Feb-02, Volume: 14, Issue:4

    Topics: Animals; Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Catalysis; Cell Line, Tumor; Cell Membrane; Drug Carriers; Drug Liberation; Female; Ferric Compounds; Humans; Hydroxyl Radical; Macrophages; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms; Porosity; Precision Medicine; Sulfonamides; Tumor Microenvironment

2022